<div id="readability-page-1"><p>Lemonade, Inc. (NYSE:LMND - Get Free Report) COO Adina Eckstein sold 7,919 shares of the firm's stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $81.15, for a total value of $642,626.85. Following the sale, the chief operating officer directly owned 196,310 shares of the company's stock, valued at $15,930,556.50. The trade was a 3.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.</p><ul><li>MarketBeat Week in Review – 11/03 - 11/07</li></ul><p>Adina Eckstein also recently made the following trade(s): </p><ul><li>On Tuesday, December 9th, Adina Eckstein sold 29,237 shares of Lemonade stock. The stock was sold at an average price of $77.17, for a total transaction of $2,256,219.29. </li><li>On Monday, December 8th, Adina Eckstein sold 41,557 shares of Lemonade stock. The shares were sold at an average price of $78.95, for a total transaction of $3,280,925.15. </li><li>On Monday, November 10th, Adina Eckstein sold 5,988 shares of Lemonade stock. The stock was sold at an average price of $78.00, for a total transaction of $467,064.00. </li><li>On Friday, November 7th, Adina Eckstein sold 40,000 shares of Lemonade stock. The shares were sold at an average price of $73.02, for a total transaction of $2,920,800.00. </li></ul><h2>Lemonade Stock Up 4.6%</h2><p>NYSE:LMND traded up $3.61 during trading hours on Thursday, reaching $81.98. 4,178,212 shares of the stock were exchanged, compared to its average volume of 2,442,477. Lemonade, Inc. has a twelve month low of $24.31 and a twelve month high of $84.52. The business has a 50-day moving average of $64.67 and a two-hundred day moving average of $52.61. The company has a market capitalization of $6.13 billion, a price-to-earnings ratio of -34.30 and a beta of 2.13. </p><ul><li>Is Lemonade Stock Set for a Big Squeeze After Earnings?</li></ul><p>Lemonade (NYSE:LMND - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported ($0.51) earnings per share for the quarter, beating analysts' consensus estimates of ($0.72) by $0.21. Lemonade had a negative return on equity of 31.86% and a negative net margin of 26.39%.The business had revenue of $194.50 million during the quarter, compared to analysts' expectations of $185.06 million. During the same period in the previous year, the firm posted ($0.95) earnings per share. The company's revenue was up 42.4% on a year-over-year basis.  On average, research analysts forecast that  Lemonade, Inc. will post -3.03 EPS for the current fiscal year. </p><h2>Institutional Trading of Lemonade</h2><p>Hedge funds and other institutional investors have recently bought and sold shares of the business. Titleist Asset Management LLC boosted its position in shares of  Lemonade by 4.1% during the 3rd quarter. Titleist Asset Management LLC now owns 4,832 shares of the company's stock worth $259,000 after acquiring an additional 189 shares in the last quarter.  Ameritas Investment Partners Inc. raised its position in shares of  Lemonade by 4.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,683 shares of the company's stock worth $249,000 after acquiring an additional 220 shares in the last quarter.  CWM LLC lifted its stake in  Lemonade by 9.9% during the third quarter. CWM LLC now owns 2,518 shares of the company's stock worth $135,000 after purchasing an additional 227 shares during the last quarter.  Migdal Insurance &amp; Financial Holdings Ltd. boosted its holdings in  Lemonade by 30.7% in the second quarter. Migdal Insurance &amp; Financial Holdings Ltd. now owns 1,034 shares of the company's stock valued at $45,000 after purchasing an additional 243 shares in the last quarter.  Finally, Watershed Private Wealth LLC increased its stake in  Lemonade by 4.9% in the third quarter. Watershed Private Wealth LLC now owns 8,170 shares of the company's stock valued at $437,000 after purchasing an additional 380 shares during the last quarter. 80.30% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Wall Street Analyst Weigh In</h2><ul><li>5 Small Cap Stocks With Explosive Upside Potential</li></ul><p>LMND has been the subject of a number of research reports. BMO Capital Markets lifted their price objective on shares of Lemonade from $23.00 to $42.00 and gave the company an &#34;underperform&#34; rating in a report on Monday, August 18th. Morgan Stanley lifted their target price on Lemonade from $49.00 to $53.00 and gave the company an &#34;underweight&#34; rating in a report on Monday, November 17th. Citizens Jmp boosted their target price on Lemonade from $60.00 to $80.00 and gave the stock a &#34;market outperform&#34; rating in a research note on Monday, November 24th. Citigroup  restated a &#34;market outperform&#34; rating on shares of Lemonade in a report on Monday, November 24th. Finally, Cantor Fitzgerald upgraded Lemonade to a &#34;strong-buy&#34; rating in a research note on Wednesday, August 13th. One investment analyst  has rated the stock with a Strong Buy rating, two have issued  a Buy rating, one  has given a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of &#34;Hold&#34; and a consensus price target of $58.57.</p><p><b>Check Out Our Latest Analysis on Lemonade</b></p><h2>Lemonade Company Profile</h2> (Get Free Report)<p>Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Lemonade</li><li>Earnings Per Share Calculator: How to Calculate EPS</li><li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li><li>Trading Halts Explained</li><li>Beyond the Magnificent 7: Meet 3 of Tech’s Rising Stars</li><li>Top Biotech Stocks: Exploring Innovation Opportunities</li><li>The Quantum Fleet: Investing in the New Quantum Standard</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxNTkQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxNTkQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lemonade Right Now?</h2><p>Before you consider Lemonade, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.</p><p>While Lemonade currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LMND

<p>Lemonade, Inc. COO Adina Eckstein sold 7,919 shares at $81.15 each, totaling $642,626.85, reducing her ownership by 3.88%. Recent sales include 29,237 shares at $77.17, 41,557 shares at $78.95, 5,988 shares at $78.00, and 40,000 shares at $73.02. Lemonade's stock rose 4.6% to $81.98. The company reported better-than-expected earnings, with revenue up 42.4% year-over-year. Institutional investors hold 80.30% of the stock.</p>

Insider Selling: Lemonade (NYSE:LMND) COO Sells 7,919 Shares of Stock